142 related articles for article (PubMed ID: 37601064)
1. Editorial: Advances in and applications of predictive toxicology: 2022.
Najjar A; Kramer N; Gardner I; Hartung T; Steger-Hartmann T
Front Pharmacol; 2023; 14():1257423. PubMed ID: 37601064
[No Abstract] [Full Text] [Related]
2. Editorial: Application of computational tools to health and environmental sciences, Volume II.
Ruiz P; Loizou G
Front Pharmacol; 2022; 13():1102431. PubMed ID: 36532722
[No Abstract] [Full Text] [Related]
3. Factors Affecting the Perception of New Approach Methodologies (NAMs) in the Ecotoxicology Community.
Mondou M; Hickey GM; Rahman HT; Maguire S; Pain G; Crump D; Hecker M; Basu N
Integr Environ Assess Manag; 2020 Mar; 16(2):269-281. PubMed ID: 31944596
[TBL] [Abstract][Full Text] [Related]
4. An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs).
Avila AM; Bebenek I; Bonzo JA; Bourcier T; Davis Bruno KL; Carlson DB; Dubinion J; Elayan I; Harrouk W; Lee SL; Mendrick DL; Merrill JC; Peretz J; Place E; Saulnier M; Wange RL; Yao J; Zhao D; Brown PC
Regul Toxicol Pharmacol; 2020 Jul; 114():104662. PubMed ID: 32325112
[TBL] [Abstract][Full Text] [Related]
5. Application of physiologically based pharmacokinetic modelling to combination toxicology.
Simmons JE
Food Chem Toxicol; 1996; 34(11-12):1067-73. PubMed ID: 9119317
[TBL] [Abstract][Full Text] [Related]
6. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.
Andersen ME
Toxicol Lett; 1995 Sep; 79(1-3):35-44. PubMed ID: 7570672
[TBL] [Abstract][Full Text] [Related]
7. Gaps and challenges in nonclinical assessments of pharmaceuticals: An FDA/CDER perspective on considerations for development of new approach methodologies.
Avila AM; Bebenek I; Mendrick DL; Peretz J; Yao J; Brown PC
Regul Toxicol Pharmacol; 2023 Mar; 139():105345. PubMed ID: 36746323
[TBL] [Abstract][Full Text] [Related]
8. Accelerating the Pace of Chemical Risk Assessment.
Kavlock RJ; Bahadori T; Barton-Maclaren TS; Gwinn MR; Rasenberg M; Thomas RS
Chem Res Toxicol; 2018 May; 31(5):287-290. PubMed ID: 29600706
[TBL] [Abstract][Full Text] [Related]
9. Advancing New Approach Methodologies (NAMs) for Tobacco Harm Reduction: Synopsis from the 2021 CORESTA SSPT-NAMs Symposium.
Lee KM; Corley R; Jarabek AM; Kleinstreuer N; Paini A; Stucki AO; Bell S
Toxics; 2022 Dec; 10(12):. PubMed ID: 36548593
[TBL] [Abstract][Full Text] [Related]
10. New approach methodologies (NAMs) for human-relevant biokinetics predictions. Meeting the paradigm shift in toxicology towards an animal-free chemical risk assessment.
Punt A; Bouwmeester H; Blaauboer BJ; Coecke S; Hakkert B; Hendriks DFG; Jennings P; Kramer NI; Neuhoff S; Masereeuw R; Paini A; Peijnenburg AACM; Rooseboom M; Shuler ML; Sorrell I; Spee B; Strikwold M; Van der Meer AD; Van der Zande M; Vinken M; Yang H; Bos PMJ; Heringa MB
ALTEX; 2020; 37(4):607-622. PubMed ID: 32521035
[TBL] [Abstract][Full Text] [Related]
11. Computational Biology and
Knudsen TB; Spencer RM; Pierro JD; Baker NC
Curr Opin Toxicol; 2020 Dec; 23-24(Oct-Dec 2020):119-126. PubMed ID: 36561131
[TBL] [Abstract][Full Text] [Related]
12. Toxicokinetic modeling and its applications in chemical risk assessment.
Andersen ME
Toxicol Lett; 2003 Feb; 138(1-2):9-27. PubMed ID: 12559690
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Chemical testing using new approach methodologies (NAMs).
Stucki AO; Clippinger AJ; Henry TR; Hirn C; Stedeford TJ; Terry C
Front Toxicol; 2022; 4():1048900. PubMed ID: 36438078
[No Abstract] [Full Text] [Related]
14. The use of physiologically-based pharmacokinetic/pharmacodynamic dosimetry models for chemical mixtures.
Yang RS; el-Masri HA; Thomas RS; Constan AA
Toxicol Lett; 1995 Dec; 82-83():497-504. PubMed ID: 8597101
[TBL] [Abstract][Full Text] [Related]
15. Consensus recommendations to promote and advance predictive systems toxicology and toxicogenomics.
Waters M; Yauk C
Environ Mol Mutagen; 2007 Jun; 48(5):400-3. PubMed ID: 17567851
[TBL] [Abstract][Full Text] [Related]
16. Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling.
Yang RS; Thomas RS; Gustafson DL; Campain J; Benjamin SA; Verhaar HJ; Mumtaz MM
Environ Health Perspect; 1998 Dec; 106 Suppl 6(Suppl 6):1385-93. PubMed ID: 9860897
[TBL] [Abstract][Full Text] [Related]
17. Computational toxicology: heading toward more relevance in drug discovery and development.
Johnson DE; Rodgers AD
Curr Opin Drug Discov Devel; 2006 Jan; 9(1):29-37. PubMed ID: 16445115
[TBL] [Abstract][Full Text] [Related]
18. Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project.
Escher SE; Kamp H; Bennekou SH; Bitsch A; Fisher C; Graepel R; Hengstler JG; Herzler M; Knight D; Leist M; Norinder U; Ouédraogo G; Pastor M; Stuard S; White A; Zdrazil B; van de Water B; Kroese D
Arch Toxicol; 2019 Dec; 93(12):3643-3667. PubMed ID: 31781791
[TBL] [Abstract][Full Text] [Related]
19. Emerging approaches in predictive toxicology.
Zhang L; McHale CM; Greene N; Snyder RD; Rich IN; Aardema MJ; Roy S; Pfuhler S; Venkatactahalam S
Environ Mol Mutagen; 2014 Dec; 55(9):679-88. PubMed ID: 25044351
[TBL] [Abstract][Full Text] [Related]
20. Application of Modelling and Simulation Approaches to Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies in Pediatric Population.
Lim A; Sharma P; Stepanov O; Reddy VP
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
